Martin Leblanc

President and CEO, Caprion Proteomics

Mr. Martin LeBlanc has led the development of proteomics technology and services at Caprion by estab-lishing revenue-generating biomarker-and-therapeutic-target-discovery alliances with over 30 major pharmaceutical and biotech companies.

Related Articles